Summary of the Get With the Guidelines-Heart Failure program impact as of 2024. CAH indicates critical access hospital. Credit: Circulation: Heart Failure (2025). DOI: 10.1161/CIRCHEARTFAILURE.125 ...

“Heart failure is a disease that never goes away, and treating it relies heavily on a patient’s ability to follow specific instructions, monitor their symptoms and keep up with many different ...

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.

Pope Francis died of a cerebral stroke and heart failure, the head of the Vatican’s health department, Dr. Andrea Arcangeli, confirmed Monday, April 21.. Francis, who was 88, suffered a stroke ...

Patients with heart failure have been advised to restrict fluids for decades, and the advice appears as recently as 2022 in US guidelines. However, fluid restriction is based on an intuitive idea ...

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests. Global cognition and executive functioning ...

But the biggest factor, doctors said, is likely the rise in metabolic risk factors like obesity and diabetes — and in ever-younger patients. In 2021, there were nearly 48 heart failure deaths ...

Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors.

And results of the SUMMIT trial—reported last month at the American Heart Association (AHA) 2024 Scientific Sessions—showed that tirzepatide (Zepbound; Eli Lilly), a dual glucose-dependent ...

Congenital heart failure as well as side effects of chemotherapy in children will be targets for this miracle therapy. Millions of children around the world suffer daily from these conditions.

Doctors and specialists at the Murdoch Children's Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure in children.